New tool to determine the risk of prostate cancer death

A new prognostic biomarker has been identified by researchers: the neuropeptide pro-NPY, which may help determine the risk of dying from prostate cancer. This particular type of protein is very specific to prostate cancer cells and could help identify whether newly diagnosed patients require radical prostatectomy surgery or if it is safe to delay surgery.

from Today's Healthcare News -- ScienceDaily http://ift.tt/1noaKIn